The Boston Scientific Connected Patient Challenge III (#CPCIoT)


  • Director Materials Science at Boston Scientific
    Director Materials Science at Boston Scientific
    Mark Boden, PhD, is a Senior Research Fellow at Boston Scientific where he is in charge of identifying, creating, and developing medical devices to improve patient care. He has technical expertise in biomaterials, infection control and prevention, device design, university and hospital collaboration, exploratory research, and identification and development of strategic growth areas. Dr. Boden is on the Advisory Boards at the National Academy of Sciences, Biomedical Engineering Materials and Applications; Massachusetts Medical Device and Development Incubator; NHLBI; Syracuse University Biomaterials Institute; UMass Lowell; and the University of Vermont.
    • Medical Devices
    • Biomaterials
    • Opportunity Evaluation
    • Technology Innovation
    • Combination Products
    • Analyical chemistry
    • Global Innovation Manager at Boston Scientific


    Kate Taylor is a Global Innovation Manager at Boston Scientific, responsible for the coordination of various internal and external innovation programs across the company. Before this she was a Medical Device Innovation Fellow at the University of Minnesota in the area of digital health investigating the link between physiological markers and chronic pain with wearable sensors.  She served as the VP of Engineering at Entarik leading the development of specialized feeding tubes for hospitalized patients.  Kate also spent many years in Corporate R&D at Medtronic using her expertise in biomaterials, coatings and drug delivery working on a variety of medical devices including cardiac pacing, defibrillation and neuro stimulation leads, rechargeable neuro stimulators, mechanical heart valves, implantable and external drug pumps and catheters, glucose sensors and powered cutting tools. 


    Kate received her BS degree in Chemistry from the University of Virginia.  She received her MS and PhD degrees in Materials Science and Engineering from the University of Cincinnati.  Her ties with the UVA continue as a member of the Oversight Committee for the Biomedical Engineering Department's Coulter Translational Research Program.


    • Engineering Management
    • Vice President, Research & Development at Boston Scientific

    Randall L. Schiestl, PMP, is the Vice President, R&D, Global Technology at Boston Scientific Corporation where he leads a team of talented R&D engineers, scientists and technicians chartered to develop and sustain a broad family of minimally invasive medical devices. Specific responsibilities include: technology management; product design; computational analysis, packaging, labeling and sterilization engineering; university relationships, new product development facilities and labs; knowledge management; and sustaining engineering. He has global responsibility for building technical community, emerging market sourcing and managing R&D information systems across BSC. His engineering teams are located across multiple facilities both US and OUS. Mr. Schiestl (Randy) has a BSME degree from the University of Minnesota, college of Science & Engineering, high distinction He also holds MBA and Executive MBA degrees from the University of Minnesota, Carlson School of Management. Randy has completed the Medical Technology Management mini-MBA at St Thomas University and is certified as a Project Management Professional. Work history includes Honeywell, Alliant Techsystems, and Boston Scientific with functional responsibilities in project and program management, product and process development, strategic planning, mergers and acquisitions, manufacturing management, supply chain, quality, information systems, test facilities, and operations. Randy serves on multiple local and national industry advisory boards and consortiums including the Medical Devices Industry Consortium, the Medical Industry Leadership Institute, Heart Advisory Committee Medical Alley, FIRST Robotics and UMN Biomedical, Medical Device Center, Nanotechnology IABs. He received the 2011 UMAA Alumni Service Award from the University of Minnesota, College of Science & Engineering and the Design of Medical Devices Conference Award in 2012.

    • Vice President, Corporate Research at Boston Scientific
    A leader in the area of Medical Device Development and Exploratory Research, Dave Knapp has been working to treat unmet needs in coronary, cardiovascular and pulmonary medicine for 20 years. Dave’s current focus as Vice President of Corporate Research at Boston Scientific is on developing new solutions and fostering growth in White Space areas. Coordinating open collaborative efforts has been a key focus area, including developing relationships with external institutions and connecting across disciplines and functions to drive meaningful innovation. Dave has a Bachelor of Science in Chemical Engineering from the University of Michigan, Ann Arbor and a Ph.D. in Chemical Engineering and Materials Science from the University of Minnesota. His undergraduate research focused in the area of cell separation and biochemical engineering at the University of Michigan and MIT, followed by a focus on Tissue Engineering at the University of Minnesota, contributing to deeper understanding of wound healing and developing bio artificial tissues such as liver, artery and heart valve leaflets. Following his tenure as a research scientist and operations engineer at Amoco Oil Company, Dave joined the Corporate Research team at Boston Scientific to help lead a development effort in Drug Eluting Stents. Since then, Dave has held a number of roles within Boston Scientific, spanning from exploratory to commercialization phases of the development cycle for various medical technologies in the cardiovascular space. His current role in Corporate Research focuses on innovation and driving new growth in white space areas and expansion into new geographies. Dave has presented at several conferences including meetings for the American Institute of Chemical Engineers (AIChE), Institute for Electrical and Electronics Engineers (IEEE), and Society for Biomaterials. He is an author on a number of publications in the areas of biopolymer rheology, in vitro assays for cell migration and traction, and modeling mechanism of release from controlled release formulations.
  • Eyal Geffen has 18 years of demonstrated success in various management and hands on positions. He has had experience with large corporations, coupled with extensive background building and running new ventures and comprehensive knowledge of international markets. 

    Eyal is a Managing partner and founder of the Sky Ventures Group, a Boston-based investment group that provides seed funding to early-stage healthcare companies. As a Managing Partner of Sky Ventures Group, Eyal is responsible for all management and day-to-day operations.

    Eyal provides consulting services to a range of healthcare clients


  • Rob joined Redmile, as a partner in February of 2008. Rob has been an equity analyst in the medical
device industry since 1994. His coverage areas have included, among others, cardiology,
orthopedics, urology, vision care, aesthetic surgery and diabetes. Rob has held positions with Thomas
Wiesel Partners, Prudential Financial and J.P. Morgan Chase & Co. Rob began his career on Wall
Street at S.G. Warburg & Co. (now UBS) where he covered biotechnology and medical device stocks
for three years. Prior to moving to sell-side research, he spent two years with The Wilkerson Group
(now IBM), a consulting firm specializing in the assessment of the value of the healthcare technologies
and two years at Tuck School of Business at Dartmouth College and graduated from Harvard College.

    • Honeywell/James J. Renier Chair in Technology Management at University of Minnesota

    Dr. Mooradian is a Honeywell/James J. Renier Chair in Technology Management in the Technological Leadership Institute at the University of Minnesota. He is the Director of Graduate studies for the Institute’s MS degree program in Medical Device Innovation. Dan is an accomplished Med Tech innovator with numerous patents. He has successfully commercialized several medical products.  Dan is a seasoned Medical Device Executive with 17+ years of experience in the medical device industry in positions of increasing responsibility including Director of Preclinical Sciences and Director of the Research & Technology Center at Boston Scientific Corporation (2006 – 2008) and Vice President for Research & Development for Synovis Life Technologies, Inc. a position he held from 2008 -2012 culminating in the company’s acquisition by Baxter International. 

  • Director, Digital Health IT, Products, Platforms and Services at Boston Scientific
    Director, Digital Health IT, Products, Platforms and Services at Boston Scientific


    Sandra leads the Product, Platform, and Service teams within the Digital Health & Data Services organization at Boston Scientific. She is responsible for the enablement and growth of Digital Health Studio teams that incorporate innovative, user centric, agile and lean principles and practices to generate high-value and high-quality digital healthcare solutions.

    Prior to joining the Digital Health & Data Services team, Sandra supported medical device development in cardiovascular, endoscopy, urology, women's health, and other therapeutics areas, helped grow innovation practices at Boston Scientific, established herself as an intrapreneur in the company, and contributed to the company's growth as a strategist in multiple areas including digital health, sensors, data analytics, imaging, diagnostics, and regenerative medicine.


    Sandra is a native of Slovenia and holds a BS in Chemistry from Univerza v Ljubljani, Slovenia, an MS in Chemistry from Michigan State University, and a Ph.D. in Chemistry from Tufts University. Sandra is a past winner of multiple awards including the Boston Scientific CEO Winning Spirit Award, the John Abele Science & Technology Award, and three Boston Scientific Innovation Fund awards. Sandra has authored 26 patents and patent applications.


  • Mac McKeen has over 25 years of experience in the medical device industry in regulatory and quality roles focused on the development, clinical study, and regulatory approvals of cardiovascular devices and is currently a Fellow at Boston Scientific with previous leadership roles at Medtronic, St. Jude Medical, Cardiac Science and Phillips Medisize.  He also serves as an Adjunct Professor at the University of Minnesota instructing a 4000 level course on medical device development.  He is actively involved in advocacy and collaboration with the FDA through industry associations including AdvaMed and Medical Alley.  He holds a BS in Industrial Technology from Iowa State University and an MBA from the University of Dallas and is RAC certified.

  • Ralph Cardinal is the R&D Director of Electronic Medical Equipment at Boston Scientific where he leads a global R&D team to deliver medical equipment designs, solutions, technology, and systems. Prior to joining Boston Scientific Ralph held leadership and technical positions in implanted device, medical equipment R&D and Quality at Urologix, Leptos Biomedical, Guidant, InControl, and Quinton Instruments.  Ralph has a BSEE from the University of Wyoming and an MS in Computer Engineering.  He has over 25 years of experience in the medical device industry across cardiac, urology and neuromodulation.

    • Sr. R&D Manager, Corporate Research at Boston Scientific

    Bryan Clark is a Sr. R&D Manager at Boston Scientific where his current focus is on identifying and developing new solutions to solve unmet clinical needs, developing partnerships with external institutions and connecting across disciplines to drive innovation in healthcare.  He has led numerous projects and partnerships across multiple technology and disease state areas including bioelectric medicine, digital health, cardiovascular disease, pulmonary disease, urological disorders, and chronic pain.  He holds a Bachelor of Science in Composite Materials Engineering from Winona State University and an MBA from the Carlson School of Management at the University of Minnesota.   

  • Jenni Goodman is the Community Manager for PULSE@MassChallenge, the most startup-friendly digital health lab, connecting entrepreneurs to experts, institutions and resources with no equity taken. She loves working with the best entrepreneurs and digital healthcare startups in the world. She believes that when entrepreneurs and the ecosystem come together to solve problems we will accelerate innovation and transform healthcare. Prior to working at PULSE@MC, Jenni worked at The Five O'Clock Club, Pfizer and Greater Talent Network. She is passionate about building relationships & communities and helping those around her to succeed. She received a Bachelor of Science in Communications from Boston University and is currently pursuing her MBA from Babson College.

  • Shafali Hill has been with Boston Scientific Neuromodulation since 2016 and is the Director of Connectivity for Boston Scientific Neuromodulation.  She has over 15 years of experience in product development in the consumer technology and medical device sectors.  Shafali leads the development of digital innovations in support of our therapies.  Shafali has a Bachelor’s degree from the University of Calgary, A Masters in Electrical Engineering from Massachusetts Institute of Technology and a Master’s of Business Administration from MIT Sloan School of Management.  She lives in Santa Clarita, CA with her husband, son, and daughter.

  • R&D Leader, passionate about innovation and solving challenges in healthcare
    R&D Leader, passionate about innovation and solving challenges in healthcare
    • VP Digital Health at redpine signals

    Research and Development leader with more than 15-years of progressively responsible experience in global medical / healthcare equipment design and development (focused on patient monitoring systems including sensors, algorithms, hardware and software). Repeated success working closely with diverse skilled teams. Interested in the overlap between traditional medical technology and digital health (i.e. home monitoring, telemedicine, data integration, interoperability, smart sensors) and the evolution of this ecosystem to drive change, add value and improve healthcare delivery.Combination of clinical expertise coupled with design/development experience gives unique insight into understanding and translating end-user needs and challenges into successful product realization opportunities. Skilled at being at the intersection of what's next for the business and can serve in multiple functions to move the organization forward to achieve its strategic goals.Collaborative leader with a reputation for improving operational performance, embracing innovation, and building high performance teams. Demonstrated success in leading organizations through complex, challenging business conditions. 

  • Coridea is a premier Medical Device incubator driven by an innovative translational health care approach. We are developing unexpected device solutions that change the lives of cardiac, pulmonary and renal patients who have failed drug treatment.

Want to stay updated? Follow Contest & Create Submissions